Guillain-Barré syndrome after rtPA therapy for acute stroke

Neurol Sci. 2010 Dec;31(6):867-9. doi: 10.1007/s10072-010-0259-8. Epub 2010 May 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Disease
  • Aged
  • Female
  • Fibrinolytic Agents / adverse effects*
  • Guillain-Barre Syndrome / chemically induced*
  • Humans
  • Recombinant Proteins / adverse effects
  • Stroke / drug therapy*
  • Tissue Plasminogen Activator / adverse effects*

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • Tissue Plasminogen Activator